← Leaderboards
Shobha Vasudevan
Massachusetts General Hospital
$4,370,491
Attributed
$4,370,491
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $758.3K · FY2015–23$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,370,491 · 4
By mechanism
R01$2,098,077 · 2
R35$1,847,964 · 1
R21$424,450 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Samuel D Rabkin$6,893,969
- Vijaya Ramesh$9,458,883
- Priscilla Kaliopi Brastianos$4,062,816
- Daniel P. Cahill$3,140,317
- Ning Wang$4,946,887
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoCellsMessenger RnaTranslationsMalignant NeoplasmsMediatingGene ExpressionCytokineInsightBaseTranslation FactorInflammationPlayImmunityRibosomesLeukemiaCell Cycle ArrestProtein ComplexImmune System DiseasesGenetic TranscriptionMicrornasSignal TransductionProteomeRecurrence
Grant awards (13)
Specialized post-transcriptional mechanisms of gene expression in quiescence$418,173
R35 · FY2023 · GM · contact PI
Specialized post-transcriptional mechanisms of gene expression in quiescence$169,791
R35 · FY2023 · GM · contact PI
Specialized post-transcriptional mechanisms of gene expression in quiescence$420,000
R35 · FY2022 · GM · contact PI
Specialized post-transcriptional mechanisms of gene expression in quiescence$420,000
R35 · FY2021 · GM · contact PI
Role of RNA methylation in chemoresistant cancer cells$192,590
R21 · FY2021 · CA · contact PI
Specialized post-transcriptional mechanisms of gene expression in quiescence$420,000
R35 · FY2020 · GM · contact PI
Role of RNA methylation in chemoresistant cancer cells$231,860
R21 · FY2020 · CA · contact PI
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP$334,950
R01 · FY2019 · GM · contact PI
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP$334,950
R01 · FY2018 · GM · contact PI
(PQC6) Molecular Determinants of Quiescent Cancer Cells$423,327
R01 · FY2017 · CA · contact PI
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP$334,950
R01 · FY2017 · GM · contact PI
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP$334,950
R01 · FY2016 · GM · contact PI
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP$334,950
R01 · FY2015 · GM · contact PI